MLTX

MoonLake Immunotherapeutics

Company with tickers: MLTX

CIK

1821586

CUSIP

61559X104

Shares Outstanding

73,615,396

Website

https://www.moonlaketx.com

13F Activity (30d)

5 filings 3 filers

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person	Role	Change	Effective	Filed
Spike Loy	Class I Director Nominee	Appointed	2026-06-04	2026-06-09